Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 21504440)

1.

Serum interleukin-6 may modulate periodontal inflammation in type 1 diabetic subjects.

Passoja A, Knuuttila M, Hiltunen L, Karttunen R, Niemelä O, Raunio T, Vainio O, Hedberg P, Tervonen T.

J Clin Periodontol. 2011 Aug;38(8):687-93. doi: 10.1111/j.1600-051X.2011.01731.x. Epub 2011 Apr 19.

PMID:
21504440
2.

Effect of periodontal treatment on metabolic control, systemic inflammation and cytokines in patients with type 2 diabetes.

Correa FO, Gonçalves D, Figueredo CM, Bastos AS, Gustafsson A, Orrico SR.

J Clin Periodontol. 2010 Jan;37(1):53-8. doi: 10.1111/j.1600-051X.2009.01498.x. Epub 2009 Nov 24.

PMID:
19968741
3.

Serum high-density lipoprotein cholesterol level associated with the extent of periodontal inflammation in type 1 diabetic subjects.

Passoja A, Knuuttila M, Hiltunen L, Karttunen R, Niemelä O, Raunio T, Vainio O, Hedberg P, Tervonen T.

J Clin Periodontol. 2011 Dec;38(12):1071-7. doi: 10.1111/j.1600-051X.2011.01792.x. Epub 2011 Oct 9.

PMID:
22092968
4.

Changes of adiponectin and inflammatory cytokines after periodontal intervention in type 2 diabetes patients with periodontitis.

Sun WL, Chen LL, Zhang SZ, Ren YZ, Qin GM.

Arch Oral Biol. 2010 Dec;55(12):970-4. doi: 10.1016/j.archoralbio.2010.08.001.

PMID:
20889139
5.

Relationship of Porphyromonas gingivalis with glycemic level in patients with type 2 diabetes following periodontal treatment.

Makiura N, Ojima M, Kou Y, Furuta N, Okahashi N, Shizukuishi S, Amano A.

Oral Microbiol Immunol. 2008 Aug;23(4):348-51. doi: 10.1111/j.1399-302X.2007.00426.x.

PMID:
18582336
6.

Serum 1,25(OH)D level increases after elimination of periodontal inflammation in T1DM subjects.

Antonoglou G, Knuuttila M, Niemelä O, Hiltunen L, Raunio T, Karttunen R, Vainio O, Ylöstalo P, Tervonen T.

J Clin Endocrinol Metab. 2013 Oct;98(10):3999-4005. doi: 10.1210/jc.2013-1906. Epub 2013 Aug 12.

PMID:
23940127
7.

Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol.

D'Aiuto F, Nibali L, Parkar M, Suvan J, Tonetti MS.

J Dent Res. 2005 Mar;84(3):269-73.

PMID:
15723869
8.

Serum levels of cytokines in subjects with generalized chronic and aggressive periodontitis before and after non-surgical periodontal therapy: a pilot study.

Duarte PM, da Rocha M, Sampaio E, Mestnik MJ, Feres M, Figueiredo LC, Bastos MF, Faveri M.

J Periodontol. 2010 Jul;81(7):1056-63. doi: 10.1902/jop.2010.090732.

PMID:
20192617
9.

Periodontal disease in gestational and type 1 diabetes mellitus pregnant women.

Ruiz DR, Romito GA, Dib SA.

Oral Dis. 2011 Jul;17(5):515-21. doi: 10.1111/j.1601-0825.2011.01805.x. Epub 2011 Mar 3.

PMID:
21371203
10.

Effect of treatment of chronic periodontitis on levels of serum markers of acute-phase inflammatory and vascular responses.

Ide M, McPartlin D, Coward PY, Crook M, Lumb P, Wilson RF.

J Clin Periodontol. 2003 Apr;30(4):334-40.

PMID:
12694432
11.

The role of obesity as a modifying factor in patients undergoing non-surgical periodontal therapy.

Zuza EP, Barroso EM, Carrareto AL, Pires JR, Carlos IZ, Theodoro LH, Toledo BE.

J Periodontol. 2011 May;82(5):676-82. doi: 10.1902/jop.2010.100545. Epub 2010 Nov 12.

PMID:
21073330
12.

The effect of periodontal treatment on serum leptin, interleukin-6, and C-reactive protein.

Shimada Y, Komatsu Y, Ikezawa-Suzuki I, Tai H, Sugita N, Yoshie H.

J Periodontol. 2010 Aug;81(8):1118-23. doi: 10.1902/jop.2010.090741.

PMID:
20370420
13.

Periodontal disease and C-reactive protein-associated cardiovascular risk.

D'Aiuto F, Ready D, Tonetti MS.

J Periodontal Res. 2004 Aug;39(4):236-41.

PMID:
15206916
14.

Serum osteoprotegerin and periodontal destruction in subjects with type 1 diabetes mellitus.

Antonoglou G, Knuuttila M, Nieminen P, Vainio O, Hiltunen L, Raunio T, Niemelä O, Hedberg P, Karttunen R, Tervonen T.

J Clin Periodontol. 2013 Aug;40(8):765-70. doi: 10.1111/jcpe.12129. Epub 2013 Jun 12.

PMID:
23758409
15.
16.

Association of periodontal parameters with metabolic level and systemic inflammatory markers in patients with type 2 diabetes.

Chen L, Wei B, Li J, Liu F, Xuan D, Xie B, Zhang J.

J Periodontol. 2010 Mar;81(3):364-71. doi: 10.1902/jop.2009.090544.

PMID:
20192862
17.

Periodontal status affects C-reactive protein and lipids in patients with stable heart disease from a tertiary care cardiovascular clinic.

Flores MF, Montenegro MM, Furtado MV, Polanczyk CA, Rösing CK, Haas AN.

J Periodontol. 2014 Apr;85(4):545-53. doi: 10.1902/jop.2013.130255. Epub 2013 Jun 27.

PMID:
23805809
18.

Periodontitis-associated up-regulation of systemic inflammatory mediator level may increase the risk of coronary heart disease.

Nakajima T, Honda T, Domon H, Okui T, Kajita K, Ito H, Takahashi N, Maekawa T, Tabeta K, Yamazaki K.

J Periodontal Res. 2010 Feb;45(1):116-22. doi: 10.1111/j.1600-0765.2009.01209.x. Epub 2009 Jul 8.

PMID:
19602107
19.

Short-term effects of an anti-inflammatory treatment on clinical parameters and serum levels of C-reactive protein and proinflammatory cytokines in subjects with periodontitis.

Renvert S, Lindahl C, Roos-Jansåker AM, Lessem J.

J Periodontol. 2009 Jun;80(6):892-900. doi: 10.1902/jop.2009.080552.

PMID:
19485818
20.

Diabetes mellitus-associated periodontitis: differences between type 1 and type 2 diabetes mellitus.

Aspriello SD, Zizzi A, Tirabassi G, Buldreghini E, Biscotti T, Faloia E, Stramazzotti D, Boscaro M, Piemontese M.

J Periodontal Res. 2011 Apr;46(2):164-9. doi: 10.1111/j.1600-0765.2010.01324.x. Epub 2010 Nov 26.

PMID:
21108647
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk